Title |
What Should Vaccine Developers Ask? Simulation of the Effectiveness of Malaria Vaccines
|
---|---|
Published in |
PLOS ONE, September 2008
|
DOI | 10.1371/journal.pone.0003193 |
Pubmed ID | |
Authors |
Melissa A. Penny, Nicolas Maire, Alain Studer, Allan Schapira, Thomas A. Smith |
Abstract |
A number of different malaria vaccine candidates are currently in pre-clinical or clinical development. Even though they vary greatly in their characteristics, it is unlikely that any of them will provide long-lasting sterilizing immunity against the malaria parasite. There is great uncertainty about what the minimal vaccine profile should be before registration is worthwhile; how to allocate resources between different candidates with different profiles; which candidates to consider combining; and what deployment strategies to consider. |
Mendeley readers
The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 7 | 6% |
Germany | 2 | 2% |
Netherlands | 1 | <1% |
Canada | 1 | <1% |
Australia | 1 | <1% |
Unknown | 104 | 90% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 23 | 20% |
Student > Ph. D. Student | 22 | 19% |
Student > Master | 18 | 16% |
Student > Postgraduate | 8 | 7% |
Student > Doctoral Student | 8 | 7% |
Other | 22 | 19% |
Unknown | 15 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 34 | 29% |
Medicine and Dentistry | 30 | 26% |
Computer Science | 7 | 6% |
Nursing and Health Professions | 5 | 4% |
Mathematics | 4 | 3% |
Other | 16 | 14% |
Unknown | 20 | 17% |